Update COVID-19!

Since the outbreak of the COVID-19 pandemic Lichtenheldt has played a key role as a system-relevant company, because the production of alcoholic disinfectants requires our special expertise in manufacturing under explosion-protected conditions. Currently, Lichtenheldt produces about half of all products under explosion-protected conditions. The capacities are currently being used to the maximum. Modern production facilities [...]

2020-09-04T16:21:10+02:004. September 2020|

Current communication on COVID-19!

Lichtenheldt reacts to the Corona-Virus In the context of the COVID-19 pandemic, Lichtenheldt, the responsible authorities assigned Lichtenheldt a considerable importance in the fight against the virus. Being a renowned pharmaceutical contract manufacturer for liquid and semi-solid forms, we are one of the system-relevant companies in Northern Germany helping to minimize the effect of the [...]

2020-04-06T10:06:12+02:006. April 2020|

Lichtenheldt is ready for Russia serialisation and aggregation

In December 2018, a Russian federal law was passed which stipulates that drugs introduced to the Russian market from July 1, 2020 must be serialised with a crypto-code. In contrast to EU serialisation, this requirement affects all drugs and not only prescription drugs. Lichtenheldt is currently adapting to the additional requirements and will provide [...]

2020-02-18T13:19:52+01:0018. February 2020|

One year of successful EU serialisation at Lichtenheldt

With Directive 2011/62/EU, the European Union launched its initiative against counterfeit medicines. Reliable serialisation and labeling systems for pharmaceutical manufacturers are intended to prevent the trade of illegal prescription drugs. As a European pharmaceutical manufacturer, Lichtenheldt has very successfully implemented the serialisation obligation for all prescription drugs (Rx products) as of February 9, 2019. All [...]

2020-02-18T12:57:48+01:0018. February 2020|

Lichtenheldt at the CPhI 2019 in Frankfurt

The trade fair of the pharmaceutical industry (CPhI) celebrated its 30th anniversary this year. As an expanding and independent contract manufacturer, Lichtenheldt GmbH was of course also represented this year with a large exhibition stand in order to present the wide range of products and services to the visitors. For over 70 years, Lichtenheldt [...]

2019-12-02T15:07:44+01:002. December 2019|

New company values support future development

As a basis for our corporate culture 6 new company values were defined. These values have been interpreted and for daily practical use translated by the executive team and a representative number of employees of all departments. As a harmonized result, a new value-guide has been issued and  presented to all employees on 14th of [...]

2018-06-22T17:08:03+02:0022. June 2018|

Lichtenheldt presents itself in the social networks

As a modern and progressive company, we want to be both a competent partner for our customers and an attractive employer for our employees and potential applicants. Therefore, as of now we are present with a profile in the social media sites XING, LinkedIn and Facebook. Please visit us and follow our activities also here. [...]

2018-02-28T17:45:40+01:0028. February 2018|

VITAFOODS, 7 – 9 May 2019 in Geneva / CPhI Worldwide, 5 – 7 November 2019 in Frankfurt

Lichtenheldt GmbH, a family-run, medium-sized company, uses the support of the ERDF to expand internationalisation in the EU domestic market and to position itself beyond national borders as a reliable partner in the field of contract manufacturing of pharmaceutical and dietary supplements. Our goal is to make a decisive contribution to securing the supply of [...]

2018-12-18T12:35:53+01:008. January 2018|
Go to Top